Supplementary Figure 7 from Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy
Year: 2026
Type: supplementary-materials
Abstract: Figure S7. Jurkat T cell reporter activation (NFAT-EGFP) for multispecific SbCARs in cocultures with a panel of cancer cell lines.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165034545
